Torthaí cuardaigh - Chandhasin, Chandtip
- 1 - 11 toradh as 11 á dtaispeáint
-
1
-
2
NIMG-28. VALIDATION OF MODIFIED RESPONSE ASSESSMENT IN NEURO ONCOLOGY (mRANO) DETERMINED PFS AS A STRONG PREDICTOR OF OVERALL SURVIVAL IN RECURRENT GLIOBLASTOMA TREATED WITH A TARG... de réir Ellingson, Benjamin, Chandhasin, Chandtip, Coello, Melissa, Merchant, Nina, Merchant, Fahar
Foilsithe / Cruthaithe 2020Téacs -
3
Human T-Cell Leukemia Virus Type 1 Tax Attenuates the ATM-Mediated Cellular DNA Damage Response de réir Chandhasin, Chandtip, Ducu, Razvan I., Berkovich, Elijahu, Kastan, Michael B., Marriott, Susan J.
Foilsithe / Cruthaithe 2008Téacs -
4
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer de réir Antonarakis, Emmanuel S., Chandhasin, Chandtip, Osbourne, Erica, Luo, Jun, Sadar, Marianne D., Perabo, Frank
Foilsithe / Cruthaithe 2016Téacs -
5
Distinctive receptor binding properties of the surface glycoprotein of a natural Feline Leukemia Virus isolate with unusual disease spectrum de réir Bolin, Lisa L, Chandhasin, Chandtip, Lobelle-Rich, Patricia A, Albritton, Lorraine M, Levy, Laura S
Foilsithe / Cruthaithe 2011Téacs -
6
Unique Long Terminal Repeat and Surface Glycoprotein Gene Sequences of Feline Leukemia Virus as Determinants of Disease Outcome de réir Chandhasin, Chandtip, Coan, Patricia N., Pandrea, Ivona, Grant, Chris K., Lobelle-Rich, Patricia A., Puetter, Adriane, Levy, Laura S.
Foilsithe / Cruthaithe 2005Téacs -
7
CLRM-09. INCORPORATING EXTERNAL CONTROL ARM IN MDNA55 RECURRENT GLIOBLASTOMA REGISTRATION TRIAL de réir Davi, Ruthanna, Majumdar, Antara, Bexon, Martin, Butowski, Nicholas, Chandhasin, Chandtip, Coello, Melissa, Das, Sunit, Merchant, Fahar, Merchant, Nina, Reardon, David, Roessner, Martin, Sampson, John
Foilsithe / Cruthaithe 2021Téacs -
8
Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer de réir Naing, Aung, Kurzrock, Razelle, Burger, Angelika, Gupta, Sachin, Lei, Xiudong, Busaidy, Naifa, Hong, David, Chen, Helen X., Doyle, Lawrence A., Heilbrun, Lance K., Rohren, Eric, Ng, Chaan, Chandhasin, Chandtip, LoRusso, Patricia
Foilsithe / Cruthaithe 2011Téacs -
9
ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY de réir Sampson, John, Singh Achrol, Achal, Aghi, Manish, Bankiewicz, Krystof, Brem, Steven, Brenner, Andrew, Butowski, Nicholas, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Floyd, John R, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Bexon, Martin
Foilsithe / Cruthaithe 2019Téacs -
10
CTIM-13. CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, IN RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) de réir Sampson, John, Achrol, Achal, Aghi, Manish, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas
Foilsithe / Cruthaithe 2020Téacs -
11
CTIM-28. MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, FOR RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) de réir Sampson, John, Achrol, Achal Singh, Aghi, Manish K, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas
Foilsithe / Cruthaithe 2021Téacs